Laboratory automation company Astech Projects, which manufactures the Xelair, Xelize, and Xelox ranges of automated inhaler testing systems, has announced a recent transition to the ISO 9001:2015 revised international standard for Quality Management Systems (QMS). The company said, "By meeting the criteria, Astech have displayed strong leadership and management … [Read more...] about Astech Projects certified to ISO 9001:2015 standard
Products and Services
Lonza acquires Micro-Macinazione
Lonza has announced the acquisition of Swiss contract micronization company Micro-Macinazione. The company recently completed its acquisition of Capsugel which had acquired US micronization specialist Powdersize in 2015. Capsugel announced an expansion of its micronization capacity at the former Powdersize facility in Quakertown, PA in 2016, and that capacity came on … [Read more...] about Lonza acquires Micro-Macinazione
Aptuit to be acquired by Evotec
CDMO Aptuit, which provides inhaled drug development and clinical supply manufacturing services, will be acquired by German CRO Evotec for $300 million, the two companies have announced. Aptuit has about 750 employees at 3 sites in Italy, Switzerland, and the UK. In 2016, Aptuit acquired pre-clinical development specialist Kuecept, which also has extensive … [Read more...] about Aptuit to be acquired by Evotec
Acquisition of Capsugel by Lonza completed
Lonza's acquisition of CDMO Capsugelfrom KKR for $5.5 billion, which was initially announced in December 2016, is now complete, the company said. In 2011, Pfizer sold Capsugel to KKR for just under $2.4 billion, and in 2013, Capsugel expanded its OINDP development and manufacturing services when it acquired Bend Research. The announcement stated that, "With … [Read more...] about Acquisition of Capsugel by Lonza completed
Opiant licenses Intravail technology from Aegis Therapeutics
Intranasal drug developer Opiant Pharmaceuticals has signed an exclusive global licensing deal with Aegis Therapeutics for use of Aegis’ Intravail absorption enhancers with Opiant's opioid antagonists, the company said. No financial terms were disclosed. Opiant (formerly Lightlake Therapeutics) licensed its intranasal naloxone formulation for the reversal of opioid … [Read more...] about Opiant licenses Intravail technology from Aegis Therapeutics
Iconovo adds drug formulation development services, signs deal with Amneal
DPI device developer Iconovo AB announced that it has raised €.2.3 million in an oversubscribed share issue, which the company will use to fund expansion of its services to include drug formulation development. As part of that expansion, Iconovo has recently moved into larger facilities at the SmiLe Business Incubator in Medicon Village, Lund, Sweden, to support … [Read more...] about Iconovo adds drug formulation development services, signs deal with Amneal
Aptar Pharma to manufacture child-resistant and senior-friendly nasal pumps in US
Aptar Pharma has transferred manufacturing equipment for its Child-Resistant and Senior-Friendly Classic Nasal Pump from a plant in Germany to its facility in Congers, NY, the company said. According to Aptar, its child-resistant pump is used for every major brand of topical nasal decongestant spray marketed in the US. The child-resistant pump was developed in … [Read more...] about Aptar Pharma to manufacture child-resistant and senior-friendly nasal pumps in US
Nemera partners with the University of Tours for intranasal drug delivery research
Device company Nemera has announced a partnership with the Research Center for Respiratory Diseases (CEPR) at the University of Tours for investigation of a novel intranasal drug delivery method. Nemera, which was formerly known as Rexam Healthcare Devices, markets the Advancia line of nasal spray pumps. The company recently announced that it would develop … [Read more...] about Nemera partners with the University of Tours for intranasal drug delivery research
Merxin launches generic capsule based DPI for tiotropium
Generic device company Merxin has announced the launch of its MRX003 dry powder inhaler, an off-the-shelf capsule based DPI intended for generic tiotropium 505j submissions. According to an announcement by Merxin's sister company Aedestra, the MRX003 DPI has the same design and features as the HandiHaler device, including the same air flow, same NGI profile, and … [Read more...] about Merxin launches generic capsule based DPI for tiotropium
Meggle launches InhaLac 500 micronized lactose for inhalation
Lactose manufacturer Meggle has announced the launch of InhaLac 500 micronized lactose for dry powder inhalation formulations, saying "Combined with high quality and safety, this material meets the most demanding individual dry powder inhalation formulation requirements." According to the company, 90% of the particles in InhaLac 500 are less than 10 µm in size, and … [Read more...] about Meggle launches InhaLac 500 micronized lactose for inhalation